Recombinant capripoxviruses expressing proteins of bluetongue virus: Evaluation of immune responses and protection in small ruminants

Vaccine

Volumn 25, Issue 37-38, 2007, Pages 6774-6783

  Perrin, Aurélie ^a   Albina, Emmanuel ^a   Bréard, Emmanuel ^b   Sailleau, Corinne ^b   Promé, Sylvie ^a   Grillet, Colette ^a   Kwiatek, Olivier ^a   Russo, Pierre ^c   Thiéry, Richard ^c   Zientara, Stephan ^b   Cêtre Sossah, Catherine ^a  

^a CIRAD   (France)

^b INRA   (France)

^c Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Bluetongue; Capripoxvirus; Vaccine

Indexed keywords

CAPRIPOXVIRUS VACCINE; CAPSID PROTEIN; CAPSID PROTEIN VP7; NONSTRUCTURAL PROTEIN 3; PROTEIN NS1; PROTEIN VP2; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLUETONGUE ORBIVIRUS; BOVIDS; CAPRIPOXVIRUS; CELLULAR IMMUNITY; CONTROLLED STUDY; GOAT; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; ORBIVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION; SEROTYPE; SHEEP; VIRUS INFECTION;

ANIMALS; BLUETONGUE VIRUS; CAPRIPOXVIRUS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; GENE EXPRESSION; GENETIC VECTORS; GOATS; SHEEP; SURVIVAL RATE; VIRAL PROTEINS; VIRAL VACCINES;

EID: 34548314191     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.052     Document Type: Article

References (57)

1. Fries L.F., Tartaglia J., Taylo J., Kauffman E.K., Meignier B., Paoletti E., et al. Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system. Vaccine 14 5 (1996) 428-434
2. Karaca K., Sharma J.M., Winslow B.J., Junker D.E., Reddy S., Cochran M., et al. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 16 16 (1998) 1496-1503
3. Smith G.L., Mackett M., and Moss B. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302 5908 (1983) 490-495
4. Le Goff C., Fakhfakh E., Chadeyras A., Adulugba E.E., Libeau G., Hammami S., et al. Host range phylogenetic grouping of capripoxviruses. In: Makkar H.P.S., and Viljoen G.J. (Eds). Applications of Gene-Based Technologies for improving animal production and health in developing countries (2005), IEAA 727-733
5. Kitching R.P., Hammond J.M., and Taylor W.P. A single vaccine for the control of capripox infection in sheep and goats. Res Vet Sci 42 1 (1987) 53-60
6. Berhe G., Minet C., Le Goff C., Barrett T., Ngangnou A., Grillet C., et al. Development of a dual recombinant vaccine to protect small ruminants against Peste-des-Petits-Ruminants Virus and Capripoxvirus infections. J Virol 77 2 (2003) 1571-1577
7. Diallo A., Minet C., Berhe G., Le Goff C., Black D.N., Fleming M., et al. Goat immune response to capripox vaccine expressing the hemagglutinin protein of peste des petits ruminants. Ann N Y Acad Sci 969 (2002) 88-91
8. Ngichabe C.K., Wamwayi H.M., Barrett T., Ndungu E.K., Black D.N., and Bostock C.J. Trial of a capripoxvirus-rinderpest recombinant vaccine in African cattle. Epidemiol Infect 118 1 (1997) 63-70
9. Ngichabe C.K., Wamwayi H.M., Ndungu E.K., Mirangi P.K., Bostock C.J., Black D.N., et al. Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine. Epidemiol Infect 128 2 (2002) 443-449
10. Romero C.H., Barrett T., Evans S.A., Kitching R.P., Gershon P.D., Bostock C., et al. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11 (1993) 737-742
11. Romero C.H., Barrett T., Kitching R.P., Carn V.M., and Black D.N. Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet Rec 135 (1994) 152-154
12. Wallace D.B., Ellis C.E., Espach A., Smith S.J., Greyling R.R., and Viljoen G.J. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. Vaccine 24 49-50 (2006) 7181-7189
13. Davies F.G. Sheep and goatpox. In: Gibbs E.P.J. (Ed). Virus disease of food animals vol. 2 (1981), Academic press, London 7333-7348
14. Davies F.G. Lumpy skin disease, an African capripox disease in cattle. Br Vet J 147 (1991) 489-502
15. Baylis M., and Mellor P.S. Bluetongue around the Mediterranean in 2001. Vet Rec 649 (2001) 659
16. Mellor P.S., and Wittmann E.J. Bluetongue virus in the Mediterranean Basin 1998-2001. Vet Rec 164 (2002) 20-37
17. MacLachlan N.J. The pathogenesis and immunology of bluetongue virus infection of ruminants. Comp Immunol Microbiol Infect Dis 17 3-4 (1994) 197-206
18. Thiry E., Saegerman C., Guyot H., Kirten P., Losson B., Rollin F., et al. Bluetongue in northern Europe. Vet Rec 159 10 (2006) 327
19. Mellor P.S., and Bluetongue. State Vet J 4 (1994) 7-10
20. Mellor P.S., Boorman J., and Baylis M. Culicoides biting midges: their role as arbovirus vectors. Annu Rev Entomol 45 (2000) 307-340
21. Mellor P.S., and Boorman J. The transmission and geographical spread of African horse sickness and bluetongue viruses. Ann Trop Med Parasitol 89 1 (1995) 1-15
22. Gould A.R., and Hyatt A.D. The Orbivirus genus, diversity, structure, replication and phylogenetic relationships. Comp Immun Microbiol Infect Dis 17 (1994) 163-188
23. Roy P. Bluetongue virus genetics and genome structure. Virus Res 13 3 (1989) 179-206
24. DeMaula C.D., Bonneau K.R., and MacLachlan N.J. Changes in the outer capsid proteins of BTV serotype ten that abrogate neutralization by monoclonal antibodies. Virus Res 67 (2000) 59-66
25. Verwoerd D.W. Purification and characterization of bluetongue virus. Virology 38 2 (1969) 203-212
26. Verwoerd D.W., Els H.J., De Villiers E.M., and Huismans H. Structure of the Bluetongue Virus capsid. J Virol 10 4 (1972) 793-794
27. Lobato Z.I.P., Coupar B.E.H., Gray C.P., Lunt R., and Adrew E.M. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigen. Vet Immunol Immunopathol 59 (1997) 293-309
28. Roy P., French T., and Erasmus B.J. Protective efficacy of virus-like particles for bluetongue disease. Vaccine 10 (1992) 28-32
29. Roy P., Bishop D.H., Leblois H., and Erasmus B.J. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 12 (1994) 805-811
30. Dungu B., Gerdes T., and Smit T. The use of vaccination in the control of bluetongue in southern Africa. Vet Ital 40 (2004) 616-622
31. Hunter P., and Modumo J. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep. Onderstepoort J Vet Res 68 4 (2001) 331-333
32. Murray P.K., and Eaton B.T. Vaccines for bluetongue. Aust Vet J 73 6 (1996) 207-210
33. Ferrari G., De Liberato C., Scavia G., Loenzetti R., Zini M., and Farina M. Active circulation of bluetongue vaccine virus serotype 2 among unvaccinated cattle in central Italy. Prev Vet Med 68 (2005) 103-113
34. MacLachlan N.J., Osburn B.I., Stott J.L., and Ghalib H.W. Orbivirus infection of the bovine fetus. Prog Clin Bio Res 178 (1985) 79-84
35. Schultz G., and Delay P.D. Losses in newborn lambs associated with bluetongue vaccination of pregnancy ewes. J Am Vet Med Assoc 127 942 (1955) 224-226
36. Young S., and Cordy D.R. An ovine fetal encephalopathy caused by Bluetongue vaccine virus. J Neuropathol Exp Neurol 23 (1964) 635-659
37. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25 4 (2007) 672-678 [Epub 2006 Sep 5]
38. Jeggo M.H., and Wardley R.C. The induction of murine cytotoxic T lymphocytes by bluetongue virus. Arch Virol 71 3 (1982) 197-206
39. Takamatsu H., and Jeggo M.H. Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses. Immunology 66 (1989) 258-263
40. Jeggo M.H., Wardley R.C., and Brownlie J. Importance of ovine cytotoxic T cells in protection against bluetongue virus infection. Prog Clin Biol Res 178 (1985) 477-487
41. Jeggo M.H., and Wardley R.C. Generation of cross-reactive cytotoxic T lymphocytes following immunization of mice with various bluetongue virus types. Immunology 45 4 (1982) 629-635
42. Janardhana V., Andrew M.E., Lobato Z.I., and Coupar B.E. The ovine cytotoxic T lymphocyte responses to bluetongue virus. Res vet Sci 67 3 (1999) 213-221
43. Andrew M., Whiteley P., Janardhana V., Lobato Z., Gould A., and Coupar B. Antigen specific of the ovine cytotoxic T Lymphocytes response to bluetongue virus. Vet immunol immunopathol 47 3-4 (1995) 311-322
44. Wade-Evans A.M., Romero C.H., Mellor P.S., Takamatsu H., Anderson J., Thevasagayam J., et al. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220 1 (1996) 227-231
45. Stott J.L., and Osburn B.I. Immune response to bluetongue virus infection. Curr Top Microbiol Immunol 162 (1990) 163-178
46. Zientara S., Sailleau C., Dauphin G., Roquier C., Remond E.M., Lebreton F., et al. Identification of bluetongue virus serotype 2 (Corsican strain) by reverse-transcriptase PCR reaction analysis of segment 2 of the genome. Vet Rec 150 (2002) 598-601
47. Boyle D.B., and Coupar A.E.H. A dominant selectable marker for the construction of recombinant poxviruses. Gene 65 (1988) 123-128
48. Falkner F.G., and Moss B. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J Virol 62 (1988) 1849-1854
49. Dubbs D.R., and Kits S. Isolation and properties of vaccinia mutants deficient in TK inducing activity. Virology 22 (1964) 214-225
50. Boyle D.B., Coupar A.E.H., and Both G.W. Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses. Gene 35 1-2 (1985) 169-177
51. Wallace D.B., and Viljoen G.J. Immnune responses to recombinants of the South African vaccine strain of LSDV generated by using thymidine kinase gene insertion. Vaccine 23 (2005) 3061-3067
52. Libeau G., Prehaud C., Lancelot R., Colas F., Guerre L., Bishop D.H., et al. Development of a competitive ELISA for detecting antibodies to the peste des petits ruminants virus using a recombinant nucleoprotein. Res Vet Sci 58 1 (1995) 50-55
53. Clavijo A., Heckert R.A., Dulac G., and Afshar A. Isolation and identification of bluetongue virus. J Virol Methods 87 (2000) 13-23
54. Toussaint J.F., Sailleau C., Breard E., Zientara S., and De Clercq K. Bluetongue virus detection by two RT-qPCRs targeting two different genomic segments. J Virol Methods 140 1-2 (2007) 115-123
55. Katz J.B., Alstad A.D., Gustafson G.A., and Moser K.M. Sensitive identification of bluetongue virus serogroup by a colorimetric dual oligonucleotide sorbent assay of amplified viral nucleic acid. J Clin Microbiol 31 11 (1993) 3028-3030
56. Jones L.D., Williams T., Bishop D., and Roy P. Baculovirus-expressed non-structural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protection. Clin Diagn Lab Immunol 59 34 (1997) 293-309
57. Kitching R.P., and Taylor W.P. Clinical and antigenic relationship between isolates of sheep and goat pox viruses. Trop Anim Health Prod 17 2 (1985) 64-74